Why this broker thinks the A2 Milk (ASX:A2M) share price has further to fall

This infant formula company's shares have tumbled heavily this year but could still have further to fall…

| More on:
ASX shares downgrade A young woman with tattoos puts both thumbs down and scrunches her face with the bad news.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The A2 Milk Company Ltd (ASX: A2M) share price is out of form again on Monday.

In afternoon trade, the embattled infant formula company's shares are down 2% to $5.91.

This means A2 Milk's shares are now down over 49% since the start of the year.

Has the A2 Milk share price found a bottom yet?

Unfortunately for shareholders, one leading broker doesn't appear to believe the A2 Milk share price has found its bottom just yet.

A note out of Credit Suisse from last week reveals that its analysts have retained their underperform rating and $5.50 price target on the company's shares.

Based on the current A2 Milk share price, this implies potential downside of 7% over the next 12 months.

What did the broker say?

According to the note, the broker highlights that infant formula prices stabilised in China in September.

It also notes that marketing activity is increasing and chat groups have been formed with daigou shoppers ahead of the major Singles Day retail sales event next month.

However, this isn't enough for the broker to change its rating. It has previously voiced its concerns over China's slowing birth rate and A2 Milk's loss of market share in stage 1 infant formula. Credit Suisse fears that the latter could act as a drag on its Stage 2 and Stage 3 product sales as this cohort ages.

Is anyone positive?

One broker that remains positive on the A2 Milk share price is Citi. It recently put a buy rating and $7.20 price target on the company's shares.

However, it has warned that there could be more bad news coming at its investor event later this month. This could include lower than expected margins.

The only potential benefit here is that that broker suspects that any weakness in A2 Milk's shares could be greeted with a takeover offer.

Time will tell which broker makes the right call.

Should you invest $1,000 in Bigtincan right now?

Before you buy Bigtincan shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Bigtincan wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Macquarie tips 40% upside for this ASX 200 real estate stock

Let's see what the broker is saying about this stock.

Read more »

Woman sits at her desk working at night, while traffic flows on a busy freeway out the window behind her.
Broker Notes

Transurban shares: Buy, hold, sell? Here's Macquarie's recommendation

Macquarie’s analysts just ran their slide rules over Transurban shares. Here’s what they found.

Read more »

A woman sits at her home computer with baby on her lap, and the winning ticket in her hand.
Consumer Staples & Discretionary Shares

Which 'enduring high-quality business' has become a forgotten ASX 200 stock?

Fundie says this ASX 200 consumer discretionary stock has been flying under investors' radar.

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
Financial Shares

Want a financial stock outside the big 4 banks? Macquarie tips 15% upside for this small cap financial

For those searching on the edges, this name could be worth a second look according to Macquarie.

Read more »

Copal miner standing in front of coal.
Resources Shares

How much upside does Macquarie tip for New Hope shares?

A softer-than-expected quarter has impacted the broker's view.

Read more »

Happy man working on his laptop.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

Two funeral workers with a laptop surrounded by cofins.
Broker Notes

Macquarie just forecast this ASX 300 dividend share could surge 37%. Here's why

Atop its passive income payouts, Macquarie expects this ASX dividend stock could leap 37% in a year.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Materials Shares

Does Macquarie rate James Hardie shares a buy, hold or sell?

The company is set to report FY25 earnings this week.

Read more »